GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Island Pharmaceuticals Ltd (ASX:ILA) » Definitions » Quick Ratio

Island Pharmaceuticals (ASX:ILA) Quick Ratio : 1.57 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Island Pharmaceuticals Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Island Pharmaceuticals's quick ratio for the quarter that ended in Dec. 2023 was 1.57.

Island Pharmaceuticals has a quick ratio of 1.57. It generally indicates good short-term financial strength.

The historical rank and industry rank for Island Pharmaceuticals's Quick Ratio or its related term are showing as below:

ASX:ILA' s Quick Ratio Range Over the Past 10 Years
Min: 1.57   Med: 8.43   Max: 53.24
Current: 1.57

During the past 3 years, Island Pharmaceuticals's highest Quick Ratio was 53.24. The lowest was 1.57. And the median was 8.43.

ASX:ILA's Quick Ratio is ranked worse than
71.28% of 1546 companies
in the Biotechnology industry
Industry Median: 3.595 vs ASX:ILA: 1.57

Island Pharmaceuticals Quick Ratio Historical Data

The historical data trend for Island Pharmaceuticals's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Island Pharmaceuticals Quick Ratio Chart

Island Pharmaceuticals Annual Data
Trend Jun21 Jun22 Jun23
Quick Ratio
28.00 8.43 7.76

Island Pharmaceuticals Semi-Annual Data
Jun20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Quick Ratio Get a 7-Day Free Trial 53.24 8.43 5.29 7.76 1.57

Competitive Comparison of Island Pharmaceuticals's Quick Ratio

For the Biotechnology subindustry, Island Pharmaceuticals's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Island Pharmaceuticals's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Island Pharmaceuticals's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Island Pharmaceuticals's Quick Ratio falls into.



Island Pharmaceuticals Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Island Pharmaceuticals's Quick Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Quick Ratio (A: Jun. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(2.049-0)/0.264
=7.76

Island Pharmaceuticals's Quick Ratio for the quarter that ended in Dec. 2023 is calculated as

Quick Ratio (Q: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(1.766-0)/1.128
=1.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Island Pharmaceuticals  (ASX:ILA) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Island Pharmaceuticals Quick Ratio Related Terms

Thank you for viewing the detailed overview of Island Pharmaceuticals's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Island Pharmaceuticals (ASX:ILA) Business Description

Traded in Other Exchanges
N/A
Address
697 Burke Road, Suite 201, Camberwell, VIC, AUS, 3124
Island Pharmaceuticals Ltd is a drug research and repurposing company focused on developing preventative or therapeutic drugs for viral infections. Its lead asset ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and another mosquito (or vector) borne diseases.

Island Pharmaceuticals (ASX:ILA) Headlines

No Headlines